We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Cemex SaB De Cv | NYSE:CX | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.16 | 2.05% | 7.98 | 8.075 | 7.94 | 7.99 | 3,746,232 | 01:00:00 |
International stocks trading in New York closed higher on Wednesday, with the Bank of New York index of American depositary receipts adding 0.8% to 153.77. The European index climbed 0.9% to 154.44, the Asian index added 0.8% to 142.84, the Latin American index rose 0.4% to 288.87 and the emerging markets index added 0.7% to 284.71. Among the companies with shares that actively traded were AstraZeneca PLC (AZN, AZN.LN).
AstraZeneca's sixth-largest investor, Legal & General Group PLC, is urging the U.K. drug giant's board to reverse its rejection of a $120 billion takeover offer from Pfizer Inc. (PFE) and engage in talks, according to The Wall Street Journal, which cited two people familiar with the situation. AstraZeneca shares rose 2% to $73.67.
The new chairman and chief executive of Mexican cement company Cemex SAB (CX, CEMEX.MX) said Tuesday the company's top priority is to recover the company's investment-grade rating, while not ruling out the possibility of making acquisitions. Shares rose 0.6% to $12.54.
BP PLC (BP, BP.LN) said it plans to seek a U.S. Supreme Court review of a lower court's rejection of the oil company's effort to stop Gulf Coast businesses from collecting payouts from the Deepwater Horizon settlement fund, even when they can't directly trace their losses to the 2010 oil spill. Shares rose 1.1% to $51.47.
Write to Anna Prior at anna.prior@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Cemex SaB De Cv Chart |
1 Month Cemex SaB De Cv Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions